Furoscix — Blue Cross Blue Shield of Illinois
Requests for NM Fully Insured or NM HIM members for a rare disease
Initial criteria
- The patient does NOT have any FDA labeled contraindications to the requested agent AND
- The requested indication is a rare disease AND ONE of the following:
- 1. The patient has another FDA labeled indication for the requested agent and route of administration OR
- 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
- For Ohio members: ALL of the following:
- A. The member resides in Ohio AND
- B. The plan is Fully Insured or HIM Shop (SG) AND
- C. The patient does NOT have any FDA labeled contraindications to the requested agent AND
- D. ONE of the following:
- 1. The patient has another FDA labeled indication for the requested agent and route of administration OR
- 2. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
- 3. The prescriber has submitted TWO articles from major peer-reviewed professional medical journals (e.g., JAMA, NEJM, Lancet) supporting the proposed use(s) as generally safe and effective
Reauthorization criteria
- Same as initial criteria
Approval duration
12 months